Terns Pharmaceuticals (TERN) Enterprise Value (2020 - 2023)
Historic Enterprise Value for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to -$266.6 million.
- Terns Pharmaceuticals' Enterprise Value fell 4234.91% to -$266.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$266.6 million, marking a year-over-year decrease of 4234.91%. This contributed to the annual value of -$283.1 million for FY2022, which is 7056.91% down from last year.
- As of Q3 2023, Terns Pharmaceuticals' Enterprise Value stood at -$266.6 million, which was down 4234.91% from -$285.6 million recorded in Q2 2023.
- Over the past 5 years, Terns Pharmaceuticals' Enterprise Value peaked at -$11.7 million during Q1 2020, and registered a low of -$297.5 million during Q1 2023.
- Moreover, its 4-year median value for Enterprise Value was -$177.2 million (2021), whereas its average is -$163.7 million.
- As far as peak fluctuations go, Terns Pharmaceuticals' Enterprise Value crashed by 157220.42% in 2021, and later surged by 2446.13% in 2022.
- Terns Pharmaceuticals' Enterprise Value (Quarter) stood at -$74.9 million in 2020, then plummeted by 121.74% to -$166.0 million in 2021, then tumbled by 70.57% to -$283.1 million in 2022, then increased by 5.83% to -$266.6 million in 2023.
- Its Enterprise Value stands at -$266.6 million for Q3 2023, versus -$285.6 million for Q2 2023 and -$297.5 million for Q1 2023.